COMP <GO>
LEGN vs ARQT // 10Y YIELD & FRED MACRO BETA
Legend Biotech Corporation (NASDAQ) VS. Arcutis Biotherapeutics Inc. (NASDAQ) • 15-METRIC TALLY: LEGN 7
— ARQT 4
▲ 10Y YIELD & FRED MACRO BETA LEADER: LEGN
LAST: $21.10 (-2.45%) • MKT CAP: $4.21B
macro-sensitivity
1.04
LAST: $31.26 (-2.53%) • MKT CAP: $4.03B
macro-sensitivity
1.00
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LEGN VS. ARQT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LEGN | ARQT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 90.20% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | -3.00% | +12.90 | LEGN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.0x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.21% | -0.16% | +2.37 | LEGN | /fcf-yield <GO> |
| Operating Margin | 13.90% | -3.30% | +17.20 | LEGN | /operating-margins <GO> |
| Net Profit Margin | 10.90% | -4.30% | +15.20 | LEGN | /net-margins <GO> |
| Revenue Growth (YoY) | 9.90% | 91.30% | -81.40 | ARQT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.74 | 7.78 | -4.04 | ARQT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 6/9 | +2.00 | LEGN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.2 | 66.0 | -6.80 | ARQT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.04 | 1.00 | +0.04 | LEGN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.5x | 24.0x | +6.50 | ARQT | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.21B | $4.03B | $175.8M | LEGN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LEGN REV | ARQT REV | LEGN GROSS % | ARQT GROSS % | LEGN FCF | ARQT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $376.1M | — | 90.2% | — | -$6.3M |
| FY 2024 | — | $196.5M | — | 90.3% | — | -$112.3M |
| FY 2023 | — | $59.6M | — | — | — | -$249.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LEGN // BETA 1.04
ARQT // BETA 1.00